Krystal Biotech buy Jefferies Financial Group Inc.
Start price
17.02.26
/
50%
€245.60
Target price
17.02.27
-
Performance (%)
-13.15%
Price
27.03.26
€213.30
Summary
This prediction is currently active. The price of Krystal Biotech has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.15%. This prediction currently runs until 17.02.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -1.976% | -1.976% |
| iShares Core DAX® | -0.479% | -12.062% |
| iShares Nasdaq 100 | -3.377% | -5.130% |
| iShares Nikkei 225® | -0.143% | -12.633% |
| iShares S&P 500 | -2.266% | -5.049% |
Comments by Jefferies_Financial_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€166.55
05.03.25
05.03.25
€228.54
05.03.26
05.03.26
34.31%
06.03.26
06.03.26
